Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says

(MedPage Today) -- Tirzepatide (Zepbound) injections reduced sleep apnea severity among patients with obesity, regardless of positive airway pressure (PAP) use, according to topline data from two phase III trials. In the SURMOUNT-OSA 1 study...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news